ClinicalTrials.Veeva

Menu

Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy (SepsAR2)

J

Johannes Gutenberg University (JGU)

Status

Withdrawn

Conditions

Severe Sepsis
Septic Shock

Treatments

Procedure: continuous veno-venous hemodialysis

Study type

Observational

Funder types

Other

Identifiers

NCT01926301
83743712

Details and patient eligibility

About

The cerebrovascular autoregulation is impaired in patients with severe sepsis and septic shock. A continuous veno-venous hemodialysis may improve impaired cerebrovascular autoregulation.

Hypothesis: continuous hemodialysis recovers impaired cerebrovascular autoregulation in patients with acute severe sepsis and septic shock.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • severe sepsis or septic shock
  • adult patients
  • possibility of transcranial Doppler ultrasound

Exclusion criteria

  • traumatic brain injury
  • known cerebrovascular diseases
  • Infection of the brain
  • chronic renal failure
  • pregnancy

Trial design

0 participants in 2 patient groups

Hemodialysis
Description:
Patients with severe sepsis or septic shock with acute renal failure and requirement of continuous veno-venous hemodialysis
Treatment:
Procedure: continuous veno-venous hemodialysis
No hemodialysis
Description:
Patients with severe sepsis or septic shock without acute renal failure and no requirement of continuous veno-venous hemodialysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems